(Q24202516)

6

0 references

Dan J. Stein

object named as

Dan J Stein

7

0 references

author name string

Rachel Rothbart

1

0 references

Taryn Amos

2

0 references

Jonathan C Ipser

4

0 references

Naomi Fineberg

Cochrane Database of Systematic Reviews

5

0 references

publication date

8 November 2013

0 references

published in

0 references

cites work

A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Effects of acute modafinil on cognition in trichotillomania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Treatment of trichotillomania with behavioral therapy or fluoxetine: a randomized, waiting-list controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Quantitative analysis of sponsorship bias in economic studies of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Systematic review: pharmacological and behavioral treatment for trichotillomania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Grey matter abnormalities in trichotillomania: morphometric magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Characteristics and phenomenology of hair-pulling: an exploration of subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Addicted to hair pulling? How an alternate model of trichotillomania may improve treatment outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Topiramate in the treatment of trichotillomania: an open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

White matter integrity in hair-pulling disorder (trichotillomania).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

The neuropsychology of trichotillomania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Functional brain imaging and pharmacotherapy in trichotillomania. Single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Trichotillomania (hair pulling disorder), skin picking disorder, and stereotypic movement disorder: toward DSM-V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Regional cerebral glucose metabolism of women with trichotillomania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

The potential role of haloperidol in the treatment of trichotillomania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

A controlled evaluation of acceptance and commitment therapy plus habit reversal for trichotillomania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

Long-term treatment of trichotillomania (hair pulling)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

7 January 2021

Case report: mixed effects of clomipramine in treating childhood trichotillomania

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

7 January 2021

The measurement of disability.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

7 January 2021

Serotonergic drugs in trichotillomania: treatment results in 12 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

7 January 2021

Trichotillomania treated with clomipramine and a topical steroid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

7 January 2021

A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

7 January 2021

An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

7 January 2021

Single modality versus dual modality treatment for trichotillomania: sertraline, behavioral therapy, or both?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

7 January 2021

The Trichotillomania Impact Project (TIP): exploring phenomenology, functional impairment, and treatment utilization.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007662.PUB2

7 January 2021